Genome wide association study (GWAS) data show LINGO2 genetic polymorphisms in human patients with cancer66, asthma67, chronic obstructive pulmonary disease68, Parkinson’s, and Inflammatory bowel disease69. This evidence concerns the gene LINGO2 and Parkinson disease.